Amalgamated Bank’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-165
| Closed | -$4K | – | 3065 |
|
|
2024
Q1 | $4K | Sell |
165
-815
| -83% | -$19.8K | ﹤0.01% | 2782 |
|
|
2023
Q4 | $13K | Sell |
980
-49
| -5% | -$650 | ﹤0.01% | 2808 |
|
|
2023
Q3 | $21K | Hold |
1,029
| – | – | ﹤0.01% | 2638 |
|
|
2023
Q2 | $28K | Buy |
1,029
+324
| +46% | +$8.82K | ﹤0.01% | 2571 |
|
|
2023
Q1 | $41K | Sell |
705
-96
| -12% | -$5.58K | ﹤0.01% | 2382 |
|
|
2022
Q4 | $41K | Hold |
801
| – | – | ﹤0.01% | 2511 |
|
|
2022
Q3 | $66K | Buy |
801
+13
| +2% | +$1.07K | ﹤0.01% | 2339 |
|
|
2022
Q2 | $53K | Buy |
788
+7
| +0.9% | +$471 | ﹤0.01% | 2448 |
|
|
2022
Q1 | $86K | Sell |
781
-66
| -8% | -$7.27K | ﹤0.01% | 2251 |
|
|
2021
Q4 | $82K | Sell |
847
-24
| -3% | -$2.32K | ﹤0.01% | 2082 |
|
|
2021
Q3 | $76K | Sell |
871
-35
| -4% | -$3.05K | ﹤0.01% | 2105 |
|
|
2021
Q2 | $140K | Buy |
906
+234
| +35% | +$36.2K | ﹤0.01% | 2076 |
|
|
2021
Q1 | $106K | Sell |
672
-59
| -8% | -$9.31K | ﹤0.01% | 1550 |
|
|
2020
Q4 | $170K | Buy |
731
+4
| +0.6% | +$930 | 0.01% | 1478 |
|
|
2020
Q3 | $159K | Sell |
727
-22
| -3% | -$4.81K | 0.01% | 1348 |
|
|
2020
Q2 | $213K | Buy |
749
+44
| +6% | +$12.5K | 0.01% | 1266 |
|
|
2020
Q1 | $203K | Sell |
705
-20
| -3% | -$5.76K | 0.01% | 1357 |
|
|
2019
Q4 | $208K | Buy |
725
+41
| +6% | +$11.8K | ﹤0.01% | 1618 |
|
|
2019
Q3 | $99K | Sell |
684
-5
| -0.7% | -$724 | ﹤0.01% | 1659 |
|
|
2019
Q2 | $62K | Buy |
+689
| New | +$62K | ﹤0.01% | 1729 |
|